Pharmaceutical Adulteration
Pharmaceutical Adulteration is the intentional addition of undeclared pharmaceutical substances to dietary supplements, distinguishing it from other forms of contamination by involving deliberate, covert formulation practices that pose significant toxicity risks to consumers.
55
Publications
2.7K
Citations
227
Authors
90
Institutions
Publications per year
2017–2026
18
Parents
55
The melamine adulteration scandal
Kirti Sharma, Manish Paradakar · Food Security · 2010 · 145 citations
Law, Psychiatry, Penology +3
Gopalakrishnan Saroja Seethapathy, D. Ganesh, Senthilkumar Umapathy et al. · International Journal of Legal Medicine · 2014 · 107 citations
1–5 of 55
227
4
h-index
3
h-index
3
h-index
3
h-index
2
h-index
1–5 of 227
90
Hospital Authority
Hong Kong, Hong Kong
3 h-index
22 publications
1K citations
United States Food and Drug Administration
Silver Spring, United States
3 h-index
10 publications
259 citations
Iranian Legal Medicine Organization
Tehran, Iran
2 h-index
5 publications
117 citations
Islamic Azad University Pharmaceutical Sciences Branch
Tehran, Iran
2 h-index
4 publications
104 citations

Federal Police of Brazil
Brasília, Brazil
2 h-index
2 publications
83 citations

Centre National de la Recherche Scientifique
Paris, France
2 h-index
7 publications
354 citations
Cambridge Health Alliance
Cambridge, United States
2 h-index
5 publications
188 citations
Consejo Superior de Investigaciones Científicas
Madrid, Spain
1 h-index
1 publications
36 citations
1–8 of 90
5 publications · 278 citations
5
h-index
5 publications · 96 citations
5
h-index
Repository · 3 publications · 126 citations
3
h-index
RTP · 2 publications · 123 citations
2
h-index
2 publications · 63 citations
2
h-index
1–5